$NVAX They are working on a recombinant nanoparticle flu vaccine with Phase 3 results out this quarter. There is a huge unmet need with the current flu vaccines on the market regarding effectiveness. This is hitting $12 prior to data release. If results are positive see you at $35 Bullish
  • 4
  • 1